Related Experiment Video
Updated: Jul 21, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report
Naram Khalayli1, Abdullah Omar2,3, Mayssoun Kudsi4,5
1Faculty of Medicine, Damascus University, Damascus, Syria.
Background:
As many people worldwide have been vaccinated, more triggered autoimmune bullous diseases have been noticed. We reported a case of new-onset pemphigus Vulgaris after COVID-19 vaccinations.
Case Presentation:
A 50 years old Syrian female presented with multiple erosions on her extremities, in addition to oral erosions and genital ulcers, after the 2nd dose of the mRNA COVID-19 vaccine. The lesions were multiple tenders and well-defined, reddish erythematous oral ulcers. At the same time the Skin examination showed hyper-pigmented patches over the extremities, a sequel of ruptured bullae. Pemphigus Vulgaris was diagnosed by histology. She continued on 35 mg/day of prednisone for another 2 weeks.
Conclusions:
Pemphigus is not a contraindication to vaccination, although it may be worse or present as a first onset.
Related Concept Videos
Vaccinations
Cross-reactivity
Allergic Drug Reactions
Endocarditis II: Clinical Features of Infective Endocarditis
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Allergic Reactions

